| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 07, 2026 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$29.00
Est. +92%
|
$15.09 | $21.22 |
Pending
|
$13.51
-10.5%
|
| Sep 23, 2026 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$26.00
Est. +93%
|
$13.50 | $14.28 |
Pending
|
$9.00
-33.3%
|
| Aug 12, 2026 |
Innate Pharma - ADR
IPHA
|
BUY |
$9.00
Est. +249%
|
$2.58 | $2.71 |
Pending
|
$1.59
-38.4%
|
| Aug 12, 2026 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$133.00
Est. +16%
|
$114.90 | $121.02 |
Pending
|
$71.73
-37.6%
|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$32.00
Est. +105%
|
$15.64 | $27.99 |
Pending
|
$16.33
+4.4%
|
| Dec 08, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$138.00
Est. +46%
|
$94.30 | $142.46 |
Target Met
|
$134.84
+43.0%
|
| Oct 30, 2025 |
Arvinas Inc
ARVN
|
BUY |
$14.00
Est. +46%
|
$9.59 | $16.14 |
Target Met
|
$6.91
-27.9%
|
| Oct 22, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$75.00
Est. +29%
|
$58.32 | $130.05 |
Target Met
|
$134.84
+131.2%
|
| Oct 10, 2025 |
Perspective Therapeutics Inc
CATX
|
BUY |
$14.00
Est. +233%
|
$4.20 | $6.16 |
Miss
|
$0.81
-80.6%
|
| Sep 09, 2025 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$87.00
Est. +94%
|
$44.93 | $124.42 |
Target Met
|
$71.73
+59.6%
|
| Jun 26, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$59.00
Est. +27%
|
$46.47 | $130.05 |
Target Met
|
$134.84
+190.2%
|
| May 02, 2025 |
Arvinas Inc
ARVN
|
BUY |
$16.00
Est. +107%
|
$7.72 | $16.14 |
Bullseye Hit (±1%)
|
$6.91
-10.5%
|
| Dec 10, 2024 |
Arvinas Inc
ARVN
|
BUY |
$69.00
Est. +181%
|
$24.59 | $25.75 |
Miss
|
$6.91
-71.9%
|